DERMIRA ($DERM) posted quarterly earnings results for Q4 2025 on Wednesday, March 25th. The company reported earnings of -$0.04 per share, beating estimates of -$0.06 by $0.02. The company also reported revenue of $16,079,999, missing estimates of $19,240,005 by $-3,160,006.
Stock price change since market close: -3.85%
You can see Quiver Quantitative's $DERM stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
DERMIRA Hedge Fund Activity
We have seen 52 institutional investors add shares of DERMIRA stock to their portfolio, and 23 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- J. GOLDMAN & CO LP added 798,366 shares (+inf%) to their portfolio in Q4 2025, for an estimated $6,155,401
- MILLENNIUM MANAGEMENT LLC added 457,812 shares (+inf%) to their portfolio in Q4 2025, for an estimated $3,529,730
- IKARIAN CAPITAL, LLC added 251,436 shares (+inf%) to their portfolio in Q4 2025, for an estimated $1,938,571
- PALE FIRE CAPITAL SE added 216,075 shares (+94.5%) to their portfolio in Q4 2025, for an estimated $1,665,938
- VANGUARD GROUP INC added 148,918 shares (+24.2%) to their portfolio in Q4 2025, for an estimated $1,148,157
- UBS GROUP AG added 145,006 shares (+99.9%) to their portfolio in Q4 2025, for an estimated $1,117,996
- SHEETS SMITH INVESTMENT MANAGEMENT added 132,904 shares (+inf%) to their portfolio in Q3 2025, for an estimated $946,276
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
